Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Ardy Arianpour, William Moffitt, Mark McDonough, Judd Jessup, and More


Ardy Arianpour is now senior vice president of business development at Ambry Genetics. He previously served as vice president of business development at the company. Arianpour joined Ambry in 2009 after holding several positions at Cogenics.

Nanosphere's former president and CEO William Moffitt has taken on the post of executive chairman at GlySure, a UK-based company that has developed a glucose monitoring system.

Moffitt left Nanosphere in February. Before he ended his tenure at the Northbrook, Ill.-based molecular diagnostics firm, he was president and CEO of i-STAT, and prior to that, he held executive posts at Baxter Healthcare and American Hospital Supply.

Combimatrix's shareholders have re-elected their board of directors to continue serving until the 2014 shareholder meeting. The re-elected board includes President and CEO Mark McDonough, former CEO and executive chairman Judd Jessup, Chief Medical Officer Richard Hockett, Scott Gottlieb, Wei Richard Ding, and Jeremy Jones.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.